Diadema Partners LP
- SEC CIK
- 0002026172
- 最新申報
- 2026/8/14
2025 年第 2 季持倉
持倉截至 2025/6/30，2025/8/14 申報。只含多頭部位，變化是跟 2025 年第 1 季比股數。
- 持股檔數
- 46
- 較 2025 年第 1 季 +3
- 總值
- $1.61 億
- 較 2025 年第 1 季 +$3,570 萬 (+28.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| SLNOSoleno Therapeutics Inc | COM | 284,152 | $2,381 萬 | 14.8% | +191,150+205.5% | 加碼 | 歷史 |
| AMGNAmgen Inc | Stock | 52,100 | $1,455 萬 | 9.0% | +52,100 | 新進 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 371,448 | $1,337 萬 | 8.3% | +163,565+78.7% | 加碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 94,042 | $1,182 萬 | 7.3% | +31,795+51.1% | 加碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 14,816 | $1,155 萬 | 7.2% | −4,486−23.2% | 減碼 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 104,473 | $1,109 萬 | 6.9% | +17,284+19.8% | 加碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 192,877 | $1,060 萬 | 6.6% | +140,000+264.8% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 198,285 | $644.6 萬 | 4.0% | +105,900+114.6% | 加碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 197,468 | $523.3 萬 | 3.3% | +93,347+89.7% | 加碼 | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 10,000 | $445.2 萬 | 2.8% | +10,000 | 新進 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 76,185 | $421.1 萬 | 2.6% | +76,185 | 新進 | 歷史 |
| GILDGilead Sciences, Inc. | Stock | 30,000 | $332.6 萬 | 2.1% | +30,000 | 新進 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 5,974 | $329.3 萬 | 2.0% | −6,305−51.3% | 減碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 104,384 | $327.6 萬 | 2.0% | +7,400+7.6% | 加碼 | 歷史 |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 5,607 | $294.4 萬 | 1.8% | −24,221−81.2% | 減碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 79,079 | $290.9 萬 | 1.8% | +79,079 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 392,213 | $281.6 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 62,926 | $222.9 萬 | 1.4% | +5,003+8.6% | 加碼 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 206,200 | $205.6 萬 | 1.3% | +206,200 | 新進 | 歷史 |
| URGNUroGen Pharma Ltd. | COM | 150,000 | $205.5 萬 | 1.3% | +73,780+96.8% | 加碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 53,985 | $196.3 萬 | 1.2% | +53,985 | 新進 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 122,061 | $170.6 萬 | 1.1% | −40,002−24.7% | 減碼 | 歷史 |
| MRKMerck & Co., Inc. | Stock | 20,000 | $158.3 萬 | 1.0% | +20,000 | 新進 | 歷史 |
| PCRXPacira BioSciences, Inc. | COM | 58,926 | $140.8 萬 | 0.9% | +20,000+51.4% | 加碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 253,657 | $108.1 萬 | 0.7% | +153,657+153.7% | 加碼 | 歷史 |
| RVPHReviva Pharmaceuticals Holdings, Inc. | COM | 2,735,457 | $104.2 萬 | 0.6% | +2,084,734+320.4% | 加碼 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | Stock | 158,536 | $102.9 萬 | 0.6% | +158,536 | 新進 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 185,830 | $101.6 萬 | 0.6% | +5,830+3.2% | 加碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 259,852 | $96.9 萬 | 0.6% | +203,754+363.2% | 加碼 | 歷史 |
| ETNB89bio, Inc. | COM | 98,382 | $96.6 萬 | 0.6% | −133,054−57.5% | 減碼 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 702,135 | $87.1 萬 | 0.5% | +32,332+4.8% | 加碼 | 歷史 |
| SCPHscPharmaceuticals Inc. | COM | 217,623 | $82.9 萬 | 0.5% | +217,623 | 新進 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM | 403,922 | $80.8 萬 | 0.5% | −162,053−28.6% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 96,455 | $71.0 萬 | 0.4% | +96,455 | 新進 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 10,572 | $45.9 萬 | 0.3% | −29,428−73.6% | 減碼 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 40,294 | $38.6 萬 | 0.2% | +40,294 | 新進 | 歷史 |
| NUVLNuvalent, Inc. | COM | 5,000 | $38.1 萬 | 0.2% | +5,000 | 新進 | 歷史 |
| ALECAlector, Inc. | COM | 266,023 | $37.2 萬 | 0.2% | −190,523−41.7% | 減碼 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 157,694 | $32.2 萬 | 0.2% | −50,000−24.1% | 減碼 | 歷史 |
| REPLReplimune Group, Inc. | COM | 32,483 | $30.2 萬 | 0.2% | −42,047−56.4% | 減碼 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 64,613 | $17.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 43,616 | $15.1 萬 | 0.1% | −382,730−89.8% | 減碼 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 362,935 | $13.3 萬 | 0.1% | +362,935 | 新進 | 歷史 |
| PRTCYPureTech Health plc | ADS | 7,324 | $12.6 萬 | 0.1% | +7,324 | 新進 | 歷史 |
| SMMTSummit Therapeutics Inc. | COM | 932 | $1.98 萬 | <0.1% | +932 | 新進 | 歷史 |
| ZLABZai Lab Ltd | ADR | 3,785 | $1.32 萬 | <0.1% | +3,785 | 新進 | 歷史 |
選擇權（41 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| LLYEli Lilly & Co | Stock | $1,614 萬 | $779.5 萬 |
| AMGNAmgen Inc | Stock | $1,734 萬 | – |
| RAREUltragenyx Pharmaceutical Inc. | COM | $448.3 萬 | $789.0 萬 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | – | $829.3 萬 |
| RVMDRevolution Medicines, Inc. | COM | – | $735.8 萬 |
| CORTCorcept Therapeutics Inc | COM | $735.5 萬 | – |
| NVONovo Nordisk A S | ADR | – | $690.2 萬 |
| APGEApogee Therapeutics, Inc. | COM | – | $678.8 萬 |
| BBIOBridgeBio Pharma, Inc. | COM | – | $567.4 萬 |
| MRNAModerna, Inc. | Stock | $275.9 萬 | $281.7 萬 |
| ALTAltimmune, Inc. | COM NEW | $66.3 萬 | $488.7 萬 |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | – | $544.8 萬 |
| JAZZJazz Pharmaceuticals plc | SHS USD | – | $530.6 萬 |
| SPRYARS Pharmaceuticals, Inc. | COM | – | $489.8 萬 |
| PFEPfizer Inc | Stock | – | $484.8 萬 |
| AGIOAgios Pharmaceuticals, Inc. | COM | – | $406.1 萬 |
| MREOMereo BioPharma Group plc | SPON ADS | $10.7 萬 | $357.1 萬 |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | – | $353.4 萬 |
| SMMTSummit Therapeutics Inc. | COM | $106.4 萬 | $159.0 萬 |
| ZYMEZymeworks Inc. | COM | – | $225.0 萬 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | $194.9 萬 | – |
| MNKDMannkind Corp | COM NEW | – | $194.4 萬 |
| ACADAcadia Pharmaceuticals Inc | COM | – | $191.8 萬 |
| SCPHscPharmaceuticals Inc. | COM | – | $185.4 萬 |
| RVPHReviva Pharmaceuticals Holdings, Inc. | COM | – | $152.4 萬 |
| COGTCogent Biosciences, Inc. | COM | $144.6 萬 | $4.95 萬 |
| QUREuniQure N.V. | SHS | – | $145.1 萬 |
| BHVNBiohaven Ltd. | COM | – | $141.1 萬 |
| OCULOcular Therapeutix, Inc | COM | – | $126.9 萬 |
| CAPRCapricor Therapeutics, Inc. | COM NEW | $105.9 萬 | – |
| ATYRaTYR PHARMA INC | COM NEW | $38.6 萬 | $65.3 萬 |
| BMEABiomea Fusion, Inc. | COM | – | $102.4 萬 |
| TNGXTango Therapeutics, Inc. | COM | – | $102.4 萬 |
| GOSSGossamer Bio, Inc. | COM | – | $101.5 萬 |
| SLSSELLAS Life Sciences Group, Inc. | COM NEW | – | $87.6 萬 |
| FOLDAmicus Therapeutics, Inc. | COM | – | $75.3 萬 |
| CRDFCardiff Oncology, Inc. | COM | – | $65.6 萬 |
| PRTAProthena Corp Public Ltd Co | SHS | – | $60.7 萬 |
| TERNTerns Pharmaceuticals, Inc. | COM | – | $60.0 萬 |
| NKTRNektar Therapeutics | COM NEW | – | $8.59 萬 |
| VTGNVistagen Therapeutics, Inc. | COM | – | $400 |
2025 年第 1 季之後清倉（14 檔）
2025 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 1 季股數 | 2025 年第 1 季市值 | 2025 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 13,115 | $354.1 萬 | 2.8% | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 50,000 | $264.9 萬 | 2.1% | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 60,000 | $264.8 萬 | 2.1% | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 164,048 | $235.9 萬 | 1.9% | 歷史 |
| NVONovo Nordisk A S | ADR | 24,618 | $167.6 萬 | 1.3% | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 135,509 | $156.4 萬 | 1.2% | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 183,466 | $145.9 萬 | 1.2% | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 8,321 | $129.7 萬 | 1.0% | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 20,000 | $80.4 萬 | 0.6% | 歷史 |
| QUREuniQure N.V. | SHS | 36,500 | $38.7 萬 | 0.3% | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 269,589 | $29.7 萬 | 0.2% | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 492,215 | $16.9 萬 | 0.1% | 歷史 |
| SGMTSagimet Biosciences Inc. | COM SER A | 46,019 | $15.0 萬 | 0.1% | 歷史 |
| CADLCandel Therapeutics, Inc. | COM | 25,045 | $14.2 萬 | 0.1% | 歷史 |